InChI=1S/C79H152N10O13S/c1-4-7-10-13-16-19-22-24-27-30-33-36-39-54-72(92)101-61-64(102-73(93)55-40-37-34-31-28-25-23-20-17-14-11-8-5-2)62-103-63-70(84-71(91)53-38-35-32-29-26-21-18-15-12-9-6-3)78(98)89-69(60-90)77(97)87-66(50-42-46-57-81)75(95)85-65(49-41-45-56-80)74(94)86-67(51-43-47-58-82)76(96)88-68(79(99)100)52-44-48-59-83/h64-70,90H,4-63,80-83H2,1-3H3,(H,84,91)(H,85,95)(H,86,94)(H,87,97)(H,88,96)(H,89,98)(H,99,100)/t64?,65-,66-,67-,68-,69-,70-/m0/s1 |
ACYXXCRNFRQHBB-RXUNMRDHSA-N |
C(CCCCCCCC)CCCCC(N[C@H](C(=O)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(=O)N[C@H](C(=O)O)CCCCN)CCCCN)=O)CCCCN)=O)CCCCN)=O)CO)CSCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC)=O |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
Toll-like receptor 2 agonist
An agonist that selectively binds to and activates the Toll-like receptor 2 (TLR 2, TLR-2) protein.
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
(via peptide antibiotic )
|
|
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
Outgoing
|
N-palmitoyl-S-[2,3-bis(palmitoyloxy)propyl]-Cys-Ser-Lys-Lys-Lys-Lys
(CHEBI:134411)
has role
antineoplastic agent
(CHEBI:35610)
N-palmitoyl-S-[2,3-bis(palmitoyloxy)propyl]-Cys-Ser-Lys-Lys-Lys-Lys
(CHEBI:134411)
has role
neuroprotective agent
(CHEBI:63726)
N-palmitoyl-S-[2,3-bis(palmitoyloxy)propyl]-Cys-Ser-Lys-Lys-Lys-Lys
(CHEBI:134411)
has role
Toll-like receptor 2 agonist
(CHEBI:77161)
N-palmitoyl-S-[2,3-bis(palmitoyloxy)propyl]-Cys-Ser-Lys-Lys-Lys-Lys
(CHEBI:134411)
is a
lipopeptide antibiotic
(CHEBI:25061)
N-palmitoyl-S-[2,3-bis(palmitoyloxy)propyl]-Cys-Ser-Lys-Lys-Lys-Lys
(CHEBI:134411)
is a
pentapeptide
(CHEBI:48545)
N-palmitoyl-S-[2,3-bis(palmitoyloxy)propyl]-Cys-Ser-Lys-Lys-Lys-Lys
(CHEBI:134411)
is a
triacyl lipopeptide
(CHEBI:60192)
|
|
S-[2,3-bis(hexadecanoyloxy)propyl]-N-tetradecanoyl-L-cysteinyl-L-seryl-L-lysyl-L-lysyl-L-lysyl-L-lysine
|
N-hexadecanoyl-S-[2,3-bis(hexadecanoyloxy)propyl]-Cys-Ser-Lys-Lys-Lys-Lys
|
ChEBI
|
N-Palmitoyl-S-(2,3-bis(palmitoyloxy)propyl)cysteinyl-seryl-lysyl-lysyl-lysyl-lysine
|
ChemIDplus
|
Pam(3)-cys-ser-(lys)(4)
|
ChemIDplus
|
Pam3CSK4
|
ChEBI
|
Tripalmitoyl-cysteinyl-seryl-lysine(4)
|
ChemIDplus
|
112208-00-1
|
CAS Registry Number
|
ChemIDplus
|
17578764
|
PubMed citation
|
Europe PMC
|
18644025
|
PubMed citation
|
Europe PMC
|
19617307
|
PubMed citation
|
Europe PMC
|
20081527
|
PubMed citation
|
Europe PMC
|
20808895
|
PubMed citation
|
Europe PMC
|
22351935
|
PubMed citation
|
Europe PMC
|
23073139
|
PubMed citation
|
Europe PMC
|
23298864
|
PubMed citation
|
Europe PMC
|
23826757
|
PubMed citation
|
Europe PMC
|
24375077
|
PubMed citation
|
Europe PMC
|
24489933
|
PubMed citation
|
Europe PMC
|
24799523
|
PubMed citation
|
Europe PMC
|
25378593
|
PubMed citation
|
Europe PMC
|
25398056
|
PubMed citation
|
Europe PMC
|
25738770
|
PubMed citation
|
Europe PMC
|
25912722
|
PubMed citation
|
Europe PMC
|
26026246
|
PubMed citation
|
Europe PMC
|
26190752
|
PubMed citation
|
Europe PMC
|
26927383
|
PubMed citation
|
Europe PMC
|
26974438
|
PubMed citation
|
Europe PMC
|
27563808
|
PubMed citation
|
Europe PMC
|
27620721
|
PubMed citation
|
Europe PMC
|
27794068
|
PubMed citation
|
Europe PMC
|
28078083
|
PubMed citation
|
Europe PMC
|
28288677
|
PubMed citation
|
Europe PMC
|
28374588
|
PubMed citation
|
Europe PMC
|
28407632
|
PubMed citation
|
Europe PMC
|
28419983
|
PubMed citation
|
Europe PMC
|
28445714
|
PubMed citation
|
Europe PMC
|
|